The article presents abstracts of breast cancer research. They include "Phase III study of docetaxel weekly versus every 3 weeks in patients with metastatic breast cancer: final results" and "The Study of Tamoxifen and Raloxifene (STAR): initial findings from teh NSABP P-2 breast cancer prevention study."